New Zealand - Healthcare, Regulatory and Reimbursement Landscape

New Zealand - Healthcare, Regulatory and Reimbursement Landscape

  • May 2021 •
  • 166 pages •
  • Report ID: 6073099 •
  • Format: PDF
New Zealand - Healthcare, Regulatory and Reimbursement Landscape

The analyst has released its latest report, “New Zealand - Healthcare, Regulatory and Reimbursement Landscape”.The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in New Zealand.

It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure.Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets.

It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by team of industry experts.

The New Zealand pharmaceutical market is one of the major pharmaceutical markets of the Southwestern Pacific region that increased from $0.65B in 2011 at a Compound Annual Growth Rate (CAGR) of 7% to $0.98B in 2019. It is forecast to reach about $1.47B in 2025. The growth in the market is attributed to high levels of research and development, growing elderly population, and a strong clinical trial environment. However, an underfunded medicine budget and increased timelines for medicine funding pose barriers to the pharmaceutical industry. The New Zealand medical devices market was estimated to be $0.92B in 2015, which increased at a CAGR of 6% to reach $1.24B in 2020. The market is expected to grow at a CAGR of 5% from to reach $1.59B in 2025.

The report provides information on the healthcare, regulatory, and reimbursement landscape in New Zealand, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Roche, GSK, Pfizer, AstraZeneca, and Blis Technologies.
- Profiles and SWOT analyses of the major players in the medical device market: GE Healthcare, Zimmer Biomet, Alcon, Olympus, and Fisher & Paykel Healthcare.
- An insightful review of the COVID-19 epidemiology, COVID-19 impact, and developments in healthcare market, healthtech landscape, reimbursement, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in New Zealand healthcare market

Reasons to Buy
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving New Zealand healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact New Zealand healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

We are very sorry, but an error occurred.
Please contact if the problem remains.